astrazeneca oral glp 1 AstraZeneca's GLP-1 scored phase 2 wins, but no data yet AstraZeneca advances oral GLP-1 elecoglipron

Who Is This Drug Best For

Risk factors that might warrant consideration of medication adjustment include: Recent initiation or dose escalation of GLP-1 therapy Significant gastrointestinal symptoms (nausea, vomiting, early satiety) Maximum medication doses Known gastroparesis or other conditions affecting gastric emptying For patients where holding the medication is deemed appropriate, the duration should be individualized based on the specific medication, patient factors, and clinical judgment

What if I've tried everything else and nothing's worked

Experiencing a bad taste in your mouth whilst taking GLP-1 medications is an uncommon but recognised side effect that can affect some patients during treatment

Lv et al., 2014